Profile
Paul Cowan served as Chairman and Chief Executive Officer at Quotient Bioscience Ltd., Pharmaron UK Ltd., and Quotient Ltd. He also served as Chief Financial Officer, Secretary, and Treasurer at Inveresk Research Group, Inc. from 2001 to 2004.
Cowan obtained an undergraduate degree from Queensland University of Technology.
Former positions of Paul Cowan
| Companies | Position | End |
|---|---|---|
| QUOTIENT LIMITED | Chief Executive Officer | 26/03/2018 |
Inveresk Research Group, Inc.
Inveresk Research Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug development services | Director of Finance/CFO | 01/01/2004 |
Pharmaron UK Ltd.
Pharmaron UK Ltd. Pharmaceuticals: MajorHealth Technology Provides drug development services | Chief Executive Officer | - |
Quotient Bioscience Ltd.
Quotient Bioscience Ltd. Miscellaneous Commercial ServicesCommercial Services Offers drug development services | Chief Executive Officer | - |
Training of Paul Cowan
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Inveresk Research Group, Inc.
Inveresk Research Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug development services | Commercial Services |
Queensland University of Technology
Queensland University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quotient Bioscience Ltd.
Quotient Bioscience Ltd. Miscellaneous Commercial ServicesCommercial Services Offers drug development services | Commercial Services |
Pharmaron UK Ltd.
Pharmaron UK Ltd. Pharmaceuticals: MajorHealth Technology Provides drug development services | Health Technology |
Quotient Ltd.
Quotient Ltd. Medical SpecialtiesHealth Technology Develops and manufactures conventional reagent products | Health Technology |
- Stock Market
- Insiders
- Paul Cowan
















